- Home
- AVTX vs HGTY Comparison
AVTX vs HGTY Comparison
Compare AVTX & HGTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVTX | HGTY |
|---|---|---|
| Founded | 2011 | 1984 |
| Country | United States | United States |
| Employees | N/A | 1891 |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 956.7M | 1.1B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVTX | HGTY |
|---|---|---|
| Price | $19.51 | $12.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $40.57 | $13.67 |
| AVG Volume (30 Days) | ★ 1.2M | 120.9K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,813,137.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $17.74 |
| P/E Ratio | ★ N/A | $33.16 |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $6.51 | $8.81 |
| 52 Week High | $24.27 | $14.00 |
Technical Indicators
Market Signals| Indicator | AVTX | HGTY |
|---|---|---|
| Relative Strength Index (RSI) | 57.70 | 58.33 |
| Support Level | $17.32 | $10.14 |
| Resistance Level | $20.68 | $12.44 |
| Average True Range (ATR) | 1.18 | 0.33 |
| MACD | -0.06 | -0.07 |
| Stochastic Oscillator | 67.70 | 65.28 |
Price Performance
Historical ComparisonAbout AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
About HGTY Hagerty Inc.
Hagerty Inc is a provider of specialty automotive insurance. The company underwrites, sells, and services classic car and enthusiast vehicle insurance policies. Substantial revenue is derived from Commission and fees. Geographically, it serves Europe, Canada, and the United States.